National Health Investors, Inc. (NHI) filings document the disclosures of a self-managed healthcare and senior housing REIT. Its regulatory record includes Form 8-K reports for investor presentations, supplemental financial information, material events, executive-transition governance matters and equity distribution agreements, along with registration materials tied to common stock offerings.
Proxy materials cover board matters, executive compensation and shareholder voting topics. NHI filings also describe its Real Estate Investments and SHOP segments, capital structure, NYSE-listed common stock, lease and interest-income exposures, development and construction risks, tenant, manager and borrower performance, environmental matters and other risk factors affecting senior housing and medical facility investments.
National Health Investors CFO John L. Spaid exercised stock options for 8,500 shares of common stock on February 23, 2026. The options converted into common shares at a reported price of $57.7600 per share.
To cover taxes related to these equity events, Spaid disposed of 6,312 shares of common stock and an additional 236 restricted shares at a reported price of $90.0300 per share, described as tax-withholding dispositions. Following these transactions, he directly owned 50,633.6372 shares of National Health Investors common stock.
NATIONAL HEALTH INVESTORS INC director COLDEN TRACY M J reported exercising stock options for 10,000 shares of common stock on February 19, 2026. The options converted into common shares at a reported price of $73.34 per share. To cover taxes and related obligations, 8,267 shares were disposed of through a tax-withholding transaction at $88.72 per share. After these transactions, the director directly owned 11,590 shares of NHI common stock.
National Health Investors, Inc. expanded its Board of Directors and appointed Lilly H. Donohue as a director effective February 17, 2026, with an initial term ending at the 2026 annual meeting of stockholders. She brings senior housing operating and investment experience from leadership roles at Everstory Partners, Holiday Retirement, Fortress Investment Group and BlackRock.
On the same date, President and CEO D. Eric Mendelsohn resigned as a director and was immediately re-appointed to serve until the 2026 annual meeting. This sequencing is intended to align his directorship with the company’s newly declassified board structure so that, at the 2026 annual meeting, all nominees stand for election to one-year terms.
NATIONAL HEALTH INVESTORS CEO and President D. Eric Mendelsohn exercised a stock option for 25,000 Stock Option (Right to Buy) 2025 and received 25,000 shares of Common Stock at $73.34 per share. To cover tax obligations, 22,055 Common shares were disposed of through a tax-withholding transaction at $91.02 per share, leaving 115,450 Common shares held directly after these transactions.
NATIONAL HEALTH INVESTORS INC director James R. Jobe exercised stock options for 10,000 shares of common stock on February 17, 2026. The options, labeled “Stock Option (Right to Buy) 2025,” covered 10,000 shares at a reported exercise price of $0.0000 per option.
The exercise resulted in 10,000 shares of Common Stock - Jointly held with spouse at $73.34 per share, increasing this joint holding to 41,555 shares. To cover the exercise price or tax obligations, 8,058 jointly held shares were disposed of at $91.02 per share under a tax-withholding transaction, reducing the joint position to 33,497 shares. A separate Common Stock - IRA SEP account is reported with 500 shares following the transactions.
National Health Investors director exercises options and settles taxes in shares. Director Robert A. McCabe Jr. exercised stock options for 10,000 shares of common stock at an exercise price of $73.34 per share on February 12, 2026. To cover exercise price or tax obligations, 8,180 shares of common stock were disposed of in a tax-withholding transaction at $89.66 per share. After these transactions, he directly beneficially owned 42,000.96 shares of National Health Investors common stock, including 1,742.79 shares previously acquired in 2025 through a dividend reinvestment plan.
PASCOE KEVIN CARLTON reported multiple insider transaction types in a Form 4 filing for NHI. The filing lists transactions totaling 43,463 shares at a weighted average price of $80.39 per share. Following the reported transactions, holdings were 66,265 shares.
National Health Investors (NHI) senior vice president and chief accounting officer Travis David L exercised multiple stock options on February 9, 2026, acquiring common shares through option exercises at exercise prices of $53.41 and $54.73 per share.
Following these exercises, a separate transaction used 28,868 common shares at $85.10 in a tax-withholding disposition, leaving him with 32,122 shares of NHI common stock held directly after all reported transactions.
National Health Investors director Candice W. Todd reported an option exercise and related share transactions. On 02/05/2026, she exercised 10,000 shares under a 2025 stock option at $73.34 per share, receiving 10,000 common shares. On the same date, 8,705 common shares were disposed of at $84.26 per share, leaving 1,295 common shares held directly.
National Health Investors Inc.'s Chief Investment Officer, Kevin C. Pascoe, reported multiple equity transactions in the company’s common stock. On January 30, 2026, he exercised two stock option awards for 8,500 shares each at exercise prices of $54.73 and $57.76, increasing his directly held common shares to 78,330.
On the same date, he reported a disposition coded "F" of 13,602 common shares at $82.12 per share. After these transactions, Pascoe directly beneficially owned 64,728 shares of National Health Investors common stock.